Table 1.
Percentage of patients with events of uveitis on Randomized Controlled Trials
Uveitis
Randomized Controlled Trials
% patients with events under therapy
% patients with events under placebo
Infliximab
2,9
8,6
Etanercept
1,1
3,5
Adalimumab
No results
No results
Golimumab
No results
No results
Certolizumab pegol
0,9
2,8